Myhibbin Alternatives Compared
| Myhibbin (mycophenolate mofetil) | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|---|
| Myhibbin (mycophenolate mofetil) | Tacrolimus | CellCept (mycophenolate mofetil) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. Myhibbin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Organ Transplant - Rejection Reversal, Organ Transplant - Rejection Prophylaxis, Graft Versus Host Disease, Crohn's Disease, Nephrotic Syndrome. Tacrolimus may also be used for... View more |
Prescription only
Prescribed for Organ Transplant - Rejection Prophylaxis. CellCept may also be used for purposes not listed in this medication guide. |
Related suggestions Organ Transplant, Rejection Prophylaxis
|
|||||||||||||||||||||||
| More about Myhibbin (mycophenolate mofetil) | More about Tacrolimus | More about CellCept (mycophenolate mofetil) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Tacrolimus has an average rating of 7.7 out of 10 from a total of 50 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 14% reported a negative effect. |
CellCept has an average rating of 8.3 out of 10 from a total of 35 ratings on Drugs.com. 77% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Myhibbin side effects |
View all Tacrolimus side effects |
View all CellCept side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Myhibbin prices |
View all Tacrolimus prices |
View all CellCept prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other mycophenolate mofetil brands include: CellCept | Astagraf XL, Envarsus XR, Prograf | Other mycophenolate mofetil brands include: Myhibbin | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
18 hours |
21.2 hours |
18 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 351 drugs are known to interact with Myhibbin:
|
A total of 879 drugs are known to interact with Tacrolimus:
|
A total of 351 drugs are known to interact with CellCept:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 01, 2024 |
April 08, 1994 |
May 03, 1995 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.